EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Oral Drug Delivery Systems for BCS III Drugs

Junpeng Yu iD, Peng Wang iD, Zishen Bei iD, Lulu Tan, Jiaxin Wang, Guimin Qin, Yuying Huang, Shuhua Peng, Shen Liu iD, Jielan Huang, Xiaoxiu Shi, Qiujie Chen und 4 weitere

Current Issues in Molecular Biology · 05.01.2026 · 48 (1) · 63

DOI: 10.3390/cimb48010063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 05.01.2026. Verfasst von Junpeng Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine Zhuang-Yao Medicine Research, Guangxi University of Chinese Medicine, Nanning 530200, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the 2024 Research Project of Guangxi University of Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral drugs classified under Class III of the Biopharmaceutics Classification System (BCS) are defined by high aqueous solubility yet low intestinal permeability. Their restricted oral bioavailability arises not from inadequate dissolution, but is primarily governed by the intestinal permeability barrier, coupled with substantial inter-individual variability in absorption. This review adopts the intestinal permeability barrier as its core analytical framework to dissect the key determinants of oral absorption for BCS III drugs, while presenting a comparative and critical evaluation of prevailing bioavailability enhancement strategies. From perspectives including mechanism of action, achievable magnitude of enhancement, applicable physicochemical and physiological conditions, and translational feasibility, the intrinsic mechanistic limitations and applicable boundaries of distinct strategies are delineated. Finally, this paper concludes that the absorption barriers of BCS III drugs cannot be universally surmounted by a single strategy, emphasizing the significance of mechanism-guided strategy selection for the rational design of oral drug delivery systems. In doing so, it provides a foundational basis for the rational development of oral delivery systems tailored to BCS III drugs.

Schlagwörter

Stichwörter der Autor:innen

BCS III drugsbioavailability enhancementintestinal permeability barrieroral drug delivery

Autor:innen und Institutionen

  • Institute of Traditional Chinese Medicine Zhuang-Yao Medicine Research, Guangxi University of Chinese Medicine, Nanning 530200, China.
  • Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Guangxi University of Chinese Medicine, Nanning 530200, China.

ORCID-Profile: Junpeng Yu, Peng Wang, Zishen Bei, Shen Liu, Yuanle Shen

Förderung

  • the National Natural Science Foundation of China
  • the 2024 Research Project of Guangxi University of Chinese Medicine
  • National Natural Science Foundation of China
  • 2024 Research Project of Guangxi University of Chinese Medicine

Zitieren

APA

Yu, J., Wang, P., Bei, Z., Tan, L., Wang, J., Qin, G., Huang, Y., Peng, S., Liu, S., Huang, J., Shi, X., Chen, Q., Xian, J., Shen, Y., Xia, T., & Feng, J. (2026). Recent Advances in Oral Drug Delivery Systems for BCS III Drugs. Current Issues in Molecular Biology, 48(1), 63. https://doi.org/10.3390/cimb48010063

Vancouver

Yu J, Wang P, Bei Z, Tan L, Wang J, Qin G, et al. Recent Advances in Oral Drug Delivery Systems for BCS III Drugs. Current Issues in Molecular Biology. 2026;48(1):63. doi:10.3390/cimb48010063

BibTeX
@article{Yu2026,
  author = {Yu, Junpeng and Wang, Peng and Bei, Zishen and Tan, Lulu and Wang, Jiaxin and Qin, Guimin and Huang, Yuying and Peng, Shuhua and Liu, Shen and Huang, Jielan and Shi, Xiaoxiu and Chen, Qiujie and Xian, Jinyan and Shen, Yuanle and Xia, Ting and Feng, Jianfang},
  title = {Recent Advances in Oral Drug Delivery Systems for BCS III Drugs},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {1},
  pages = {63},
  doi = {10.3390/cimb48010063}
}
Kostenlos starten →